---
title: TechNote - Radioactivity Assays for Methyltransferases
description: SAMDI Tech’s radioactivity assays overcome key challenges in drug discovery by offering key solutions
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![SAMDI\_DDW\_eblast banner\_1425px](https://info.edifydigitalmedia.com/hubfs/SAMDI_DDW_eblast%20banner_1425px.png "SAMDI_DDW_eblast banner_1425px")

TechNote - Radioactivity Assays for Methyltransferases

 

 

 

 

*Brought to you by* 

 

![samdi\_logo\_black\_red\_DDW\_111px](https://info.edifydigitalmedia.com/hs-fs/hubfs/samdi_logo_black_red_DDW_111px.png?width=111&name=samdi_logo_black_red_DDW_111px.png)

---

 

![SAMDI\_Tech\_RAD\_TechNote\_July2020\_189x189 (1)](https://info.edifydigitalmedia.com/hubfs/SAMDI_Tech_RAD_TechNote_July2020_189x189%20(1).jpeg "SAMDI_Tech_RAD_TechNote_July2020_189x189 (1)")

SAMDI Tech’s radioactivity assays overcome key challenges in drug discovery by offering key solutions, including:

- Detecting low amounts of product with sensitive assays
- Generating data rapidly with high-throughput, 384-well capabilities
- Characterising potent inhibitors by benefiting from lower enzyme concentrations

In this TechNote, learn how SAMDI Tech’s radioactivity assay characterised low turnover methyltransferase enzymes, highlighting:

- An assay format capable of measuring activities from picomolar enzyme concentrations
- Characterisation of kinetic parameters to develop assays suitable for compound characterisation
- An experienced team of biochemical experts with a collaborative approach
- A suite of label-free and beyond label-free technologies to generate high-quality data rapidly to advance drug discovery pipelines

### Download the TechNote

## Copyright 2020 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions